Black Maple Capital Management’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Black Maple Capital Management’s Portfolio LABP Stock Details LABP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,405	Closed	-$223K	–	132
2024 Q1	$223K	Buy	+10,405	New	+$69K	0.14%	90

Black Maple Capital Management's LABP Position: Q2 2024 in Review

Black Maple Capital Management sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2024, closing a stake of 10,405 shares — an estimated $223K sold.

Black Maple Capital Management first reported a position in LABP in Q1 2024 and held it in 1 quarter. The position peaked at $223K in Q1 2024. 0 funds tracked by Wall St. Rank hold LABP as of Q2 2024.

Black Maple Capital Management reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Black Maple Capital Management sold 10,405 Landos Biopharma, Inc. Common Stock shares in Q2 2024, an estimated $223K.
Black Maple Capital Management first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Black Maple Capital Management's Landos Biopharma, Inc. Common Stock position peaked at $223K in Q1 2024.
0 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2024.

Based on Black Maple Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.